Cogent Biosciences (COGT) Profit After Tax: 2017-2020
Historic Profit After Tax for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$74.8 million.
- Cogent Biosciences' Profit After Tax fell 593.60% to -$11.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$74.8 million, marking a year-over-year decrease of 135.00%. This contributed to the annual value of -$74.8 million for FY2020, which is 135.00% down from last year.
- As of FY2020, Cogent Biosciences' Profit After Tax stood at -$74.8 million, which was down 135.00% from -$31.8 million recorded in FY2019.
- In the past 5 years, Cogent Biosciences' Profit After Tax ranged from a high of -$25.5 million in FY2017 and a low of -$74.8 million during FY2020.
- Over the past 3 years, Cogent Biosciences' median Profit After Tax value was -$34.5 million (recorded in 2018), while the average stood at -$47.1 million.
- Per our database at Business Quant, Cogent Biosciences' Profit After Tax grew by 7.82% in 2019 and then slumped by 135.00% in 2020.
- Over the past 4 years, Cogent Biosciences' Profit After Tax (Yearly) stood at -$25.5 million in 2017, then plummeted by 35.46% to -$34.5 million in 2018, then rose by 7.82% to -$31.8 million in 2019, then slumped by 135.00% to -$74.8 million in 2020.